There is a debate as to whether universal drug coverage confers similar access to care at all socioeconomic status (SES) levels. Experiences in Canada may bring light to questions raised regarding access.Objective:
To assess associations between SES and access to cardiac care and outcomes in Canada's universal health care system.Design, Setting, and Patients:
All patients admitted to acute care hospitals in Quebec (QC), Ontario (ON), and British Columbia (BC), between 1996 and either 2000 (QC) or 2001 (ON, BC) with acute myocardial infarction, were identified using provincial government administrative databases (n = 145,882).Measurements:
Variables representing SES grouped at the census area level were examined in association with use of cardiac medications and procedures, survival, and readmission, while adjusting for individual-level variables. A Bayesian hierarchical logistic regression model was used to account for the nested structure of the data.Results:
Despite provincial variations in SES and drug reimbursement policies, there were generally no associations between the SES variables and access to cardiac medications or invasive cardiac procedures. The few exceptions were not consistent across SES indicators and/or provinces. Similarly, the only observed effect of SES on clinical outcomes was in BC, where there was increased 1-year mortality among patients living in less-affluent regions (adjusted odds ratios per standard deviation change in proportion of low-income households, 95% Bayesian credible intervals, QC: 1.09, 0.96–1.25; ON: 1.02, 0.95–1.08; and BC: 1.18, 1.09–1.28).Conclusions:
These results suggest that intermediary factors other than SES, such as cardiovascular risk factors, likely account for observed “wealth–health” gradients in Canada. Implementation of a universal drug coverage policy could decrease socioeconomic disparities in access to health care.